Comparative effectiveness of JAK inhibitors and biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis

BACKGROUND/AIMS: We aimed to compare the effectiveness and safety of Janus kinase inhibitors (JAKi) vs. biologic disease-modifying antirheumatic drugs (bDMARD) in Korean patients with rheumatoid arthritis (RA) who had an inadequate response to conventional synthetic DMARDs. METHODS: A quasi-experime...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Soo-Kyung, Kim, Hyoungyoung, Song, Yeo-Jin, Kim, Hye Won, Nam, Eunwoo, Lee, Shin-Seok, Lee, Hye-Soon, Park, Sung-Hoon, Lee, Yeon-Ah, Park, Min-Chan, Chang, Sung Hae, Kim, Hyoun-Ah, Kwok, Seung-Ki, Kim, Hae-Rim, Kim, Hyun-Sook, Yoon, Bo Young, Uhm, Wan-Sik, Kim, Yong-Gil, Kim, Jae Hoon, Lee, Jisoo, Choi, Jeongim, Sung, Yoon-Kyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Association of Internal Medicine 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338257/
https://www.ncbi.nlm.nih.gov/pubmed/37334513
http://dx.doi.org/10.3904/kjim.2022.369

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10338257/
https://www.ncbi.nlm.nih.gov/pubmed/37334513
http://dx.doi.org/10.3904/kjim.2022.369

Ejemplares similares